Innovating Works

ABBOTT BIOLOGICALS BV

Desconocido
DRIVE: Development of Robust and Innovative Vaccine Effectiveness ABBOTT BIOLOGICALS BV participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Influenza is a major public health problem. In a conservative estimate, influenza infects annually 60 of the 500 million inhabitants of the...
2017-08-08 - 2022-06-30 | Financiado
FLUCOP: Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protect... ABBOTT BIOLOGICALS BV participó en un FP6: Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Infl...
2015-03-01 - 2020-02-29 | Financiado
FLUCOP: Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protect... ABBOTT BIOLOGICALS BV participó en un FP7: Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Infl...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.